Joseph Pergolizzi, MD

Chief Research and Development Office and Founder
Enalare Therapeutics Inc.

Poster(s):

• (1149) ENA-001, a BK-Channel Blocker, Stimulates Breathing Without Analeptic Side Effects
  Sunday, January 21, 2024

  2:30 PM – 3:30 PM MT